$1.29
At close: Apr 17, 4:00 PM EDT
$1.29
0.000.00%
Pre-Market: Apr 17, 4:00 PM EDT
Comments
Loading...
Zentalis Pharma (ZNTL) Forecast
NewsEarningsZentalis Pharma (ZNTL) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestEdge Rankings
Stock Score Locked: Want to See it?
Benzinga Rankings give you vital metrics on any stock – anytime.
Zentalis Pharma Stock Price, Quotes and Forecasts | NASDAQ:ZNTL | Benzinga
Explore Zentalis Pharma stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for ZNTL.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Zentalis Pharma (ZNTL) stock?
You can purchase shares of Zentalis Pharma (NASDAQ:ZNTL) through any online brokerage.
Who are Zentalis Pharma (ZNTL) competitors?
Other companies in Zentalis Pharma’s space includes: Zura Bio (NASDAQ:ZURA), Anixa Biosciences (NASDAQ:ANIX), Galectin Therapeutics (NASDAQ:GALT), Quoin Pharmaceuticals (NASDAQ:QNRX) and Genelux (NASDAQ:GNLX).
What is the forecast, or price target, for Zentalis Pharma (ZNTL) stock?
Zentalis Pharma has a consensus price target of $16.52.
What is the current price for Zentalis Pharma (ZNTL)?
The stock price for Zentalis Pharma (NASDAQ: ZNTL) is $1.29 last updated April 17, 2025 at 4:00 PM EDT.
Does Zentalis Pharma (ZNTL) pay a dividend?
There are no upcoming dividends for Zentalis Pharma.
When is Zentalis Pharma (NASDAQ:ZNTL) reporting earnings?
Zentalis Pharma’s Q1 earnings are confirmed for Tuesday, May 6, 2025.
Is Zentalis Pharma (ZNTL) going to split?
There is no upcoming split for Zentalis Pharma.
What sector and industry does Zentalis Pharma (ZNTL) operate in?
Zentalis Pharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
